Latest cervical cancer Stories
WASHINGTON, Aug. 11, 2011 /PRNewswire-USNewswire/ -- A majority of states are falling short on legislative solutions to prevent and fight cancer, according to a new report released today by the American Cancer Society Cancer Action Network (ACS CAN). In a year consumed by budget shortfalls and legislative challenges, many state legislatures missed opportunities to enact laws and policies that could not only save money and generate revenue, but also save lives. The report, How Do You...
BEIJING, Aug.10, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that the Ministry of Health (the "MOH") of the People's Republic of China recently issued clinical guidelines which for the first time include FISH-based molecular cytogenetics tests as one of the tests to be performed for patients of myelodysplastic syndromes ("MDS"), chronic lymphocytic...
VENLO, The Netherlands, August 9, 2011 /PRNewswire/ -- QIAGEN N.V. ("QIAGEN") welcomes today's announcement by Cellestis Limited ("Cellestis") that the Supreme Court of Victoria has approved QIAGEN's acquisition of all of the ordinary shares in Cellestis shares by way of a scheme of arrangement ("Scheme"). Once the Scheme is implemented, eligible Cellestis shareholders will receive total cash consideration of A$3.80 per share. This will be comprised of cash from QIAGEN...
VENLO, The Netherlands, August 3, 2011 /PRNewswire/ -- QIAGEN N.V. ("QIAGEN") welcomes the announcement made today by Cellestis Limited ("Cellestis") that Cellestis shareholders have approved QIAGEN's acquisition of all of the ordinary shares in Cellestis shares by way of a scheme of arrangement ("Scheme"). Details of the voting are set out in Cellestis' announcement released earlier today. "We are delighted by the support shown from Cellestis shareholders...
Research: Breast cancer mortality in neighboring European countries with different level of breast screening but similar access to treatment: Trend analysis of WHO mortality databaseBreast cancer screening has not played a direct part in the reductions of breast cancer mortality in recent years, says a new study published on bmj.com today.An international team of researchers from France, the UK and Norway found that better treatment and improving health systems are more likely to have led to...
HAMILTON, N.J., July 20, 2011 /PRNewswire/ -- Medical Diagnostic Laboratories, L.L.C. (MDL) is a CLIA certified infectious disease laboratory which specializes in high-complexity, state-of-the-art, automated DNA-based molecular analyses. MDL is able to provide clinicians with valuable tailored diagnostic information to assist in the detection, diagnosis, evaluation, and treatment of infections. MDL, a company within the Genesis Biotechnology Group, is located in "Einstein's Alley," the...
Non-melanoma skin cancer is the most common form of malignancy in adult Caucasian populations, with more than a million cases recorded each year in the USA alone.Lifestyle risk factors"¦ butThe incidence of these cancers is continuously rising due mainly to the aging structure of Western populations, and as a result of growing prosperity, permitting more visits to countries with high sun exposure, which is a key risk factor for NMSC, as well as lifestyle habits associated with prolonged...
TUCSON, Ariz., July 19, 2011 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche has signed an agreement under which it will acquire 100 percent of mtm laboratories AG (mtm), a privately-held company based in Heidelberg, Germany. mtm is a global leader in developing in vitro diagnostics with a focus on early detection and diagnosis of cervical cancer, the largest early detection market in oncology. mtm...
BLUE BELL, Pa., July 15, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, has reported data demonstrating long-term durability of T cell immune responses of up to over two years (at the latest time measured) in 7 of 8 evaluated patients following a fourth vaccination of VGX-3100, its investigational SynCon® DNA vaccine for treating cervical dysplasia and cancer...
A new study published in the American Journal of Transplantation reveals an association between the human papillomavirus (betaPV) infection and cutaneous squamous cell carcinoma (SCC) in organ transplant recipients.HPV is known to cause cervical cancer and SCC in the anogenital area and also plays a role in some forms of head and neck cancer. SCC skin cancer is increasing in incidence worldwide and the risk is particularly high in immunosuppressed individuals such as organ transplant...
Latest cervical cancer Reference Libraries
The Colposcopy is a preventive procedure to identify a possible abnormal cells or tissue on the cervix, vagina and vulva. By illuminating and magnifying the area with a coloscope during the examination, areas of concern can be identified earlier by the colposcopist. The procedure was developed by a German physician Hans Hinselmann in 1925 with the help of Dr. Helmut Wirths. Cause for the Procedure This examination has multiple candidates. If a patient has been a victim of a sexual...
The Colposcopy is a preventive procedure to identify a possible abnormal cells or tissue on the cervix, vagina and vulva. By illuminating and magnifying the area with a coloscope during the examination, areas of concern can be identified earlier by the colposcopist. The procedure was developed by a German physician Hans Hinselmann in 1925 with the help of Dr. Helmut Wirths. Cause for the Procedure This examination has multiple candidates. If a patient has been a victim of a sexual assault...
A human papillomavirus (HPV), a member of the papillomavirus family, is capable of infecting humans. HPVs establish productive infections in the skin or mucous membranes. Most of the 200 known types cause no symptoms in most people. Some types can cause warts, while others can lead to cancer. There are more than 30 to 40 types of HPV that are typically transmitted through sexual contact and infect the anogenital region. High risk HPV, can lead to cancer, in fact HPV infection is a cause of...
